Is HALP score a predictor of poor prognosis in patients with hematologic malignancies admitted to the intensive care unit?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Is HALP score a predictor of poor prognosis in patients with hematologic malignancies admitted to the intensive care unit? ; volume:36 ; number:1 ; day:1 ; month:8 ; year:2024 ; pages:1-8 ; date:12.2024
The Egyptian Journal of Internal Medicine ; 36, Heft 1 (1.8.2024), 1-8, 12.2024
- Creator
-
Sadri, Sevil
Tunay, Burcu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43162-024-00339-z
- URN
-
urn:nbn:de:101:1-2410250907402.837930914635
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sadri, Sevil
- Tunay, Burcu
- SpringerLink (Online service)
Other Objects (12)
Hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Targeting the integrated stress response in hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Targeting the integrated stress response in hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Targeting the integrated stress response in hematologic malignancies